WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'5901 Infant (under 12 months) mortality rate: 242
GDP / capita (US$): 7'7071 Child (under 5 years) mortality rate: 292

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 16'582  16'252  15'924  15'596  15'271  11'651  9'264  7'283 
Births 419  417  414  412  409  413  362  320 
Surviving infants 410  407  404  401  398  396  340  291 
Pop. less than 5 years 2'023  1'994  1'976  1'954  1'936  1'895  1'580  1'346 
Pop. less than 15 years 5'913  5'889  5'871  5'844  5'812  5'095  4'248  3'367 
Female 15-49 years 4'401  4'286  4'167  4'052  3'938  2'784  2'074  1'593 

Number of reported cases

(Click for retrospective incidence data for Guatemala)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  8'802  2'703 
Mumps
ChartChart
  517  143 
Pertussis
ChartChart
  152  83  25  34  273  146  130  1'513 
Polio*
ChartChart
  287 
Rubella
ChartChart
  276 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  60 
Tetanus (total)**
ChartChart
  11  60  60 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Guatemala)
Vaccine year result method % card seen                                                
BCG 2013  98  DHS   91  87  89  91  97  94  95  62  36 
DTP1 2013  98  DHS   91  96  99*  89  99*  99*  94 
DTP3 2013  85  DHS   91  80  74  73  93  96  95  66  43 
DTP4          71  86  56 
IPV1          91 
HepB_BD          38  32  22  37  35 
HepB3 2013  85  DHS   91  80  74  73  93  96 
Hib3 2013  85  DHS   91  80  74  73  93  96 
JapEnc         
MCV1          86  99  67  93  93  86  68  23 
MCV2          65  59 
MenA         
PCV1          95  99*  78  88 
PCV2          87  85  60  58 
PCV3          81  82  51  24 
Pol3 2013  83  DHS   91  82  90  65  92  94  93  74  43 
Rota1          94  99  65  99*  99* 
RotaC 2013  83  DHS   91  82  79  54  88  81 
RCV1          86  99  67  93  93 
TT2plus 2001  49  MCH   69  99*  99*  99*  99*  22  27 
PAB         
VAD1          66  75  64  46  34  49 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Guatemala)
BCG
ChartChart
  87  89  91  88  94  95  62  36 
DTP1
ChartChart
  96  99  89  97  96  94  86  68 
DTP3
ChartChart
  80  74  73  85  96  81  66  43 
HepB3
ChartChart
  80  74  73  85  96 
HepB_BD
ChartChart
  38  32  22  32  35 
Hib3
ChartChart
  80  74  73  85  96 
IPV1
  91 
MCV1
ChartChart
  86  77  67  85  93  86  68  23 
MCV2
ChartChart
  65 
PCV3
ChartChart
  81  82  51  24 
Pol3
ChartChart
  82  90  65  84  94  80  74  43 
RCV1
ChartChart
  86  77  67  85  93 
RotaC
ChartChart
  82  79  54  81  81 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 338  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 41
From 80 to 89% 24
From 50 to 79% 30
Less than 50% 5
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth to <12 months; Yes
DTwP 18 months; 4 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB_Adult 1st contact; +1, +6 months; Yes at risk groups
HepB_Pediatric birth; Yes
Influenza_Adult Yes Elderly, aduts with chronic diseases, pregnant women, health care workers and risk groups
Influenza_Pediatric 6-35 months; Yes and children with chronic diseases
IPV 2 months; Yes
MMR 12, 18 months; Yes
OPV 4, 6, 18 months; 4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Rotavirus 2, 4 months; Yes
Td 1st contact; +4 weeks; +6 months; +1, +1 year; Yes or 1st contact; +4 weeks; +6 months; +10, +10 years (if not at risk)
VitaminA 6-24 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  Yes  No  No  Yes  No  Yes 
What years does the MYP cover? number   2'015      2012-2016    2011-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 338      334    335  332 

System performance

Total Nº districts in country number 338  338  334  334  334  335  332 
Nº districts with DTP3 coverage >=80% number 220  215  136  249  305  256  266 
% of districts with DTP3 coverage >=80% From 0 to 100% 65  64  41  75  91  76  80 
Nº districts with measles (MCV1) coverage >=95% number 132  233  47  141  130  71  179 
% of districts with MCV1 coverage >=95% From 0 to 100% 39  69  14  42  39  21  54 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  no  no  No  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  99  100  99  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.